Charl van Zyl

Charl van Zyl

Chief Executive Officer at H. LUNDBECK A/S
59 year
Health Technology
Commercial Services
Consumer Services

Profile

Mr. Charl van Zyl is an Executive Vice President-Neurology Solutions at UCB SA. He is on the Board of Directors at Ra Pharmaceuticals, Inc. and UCB Celltech. Mr. van Zyl was previously employed as an Executive Vice President by BSN Medical SA, an Executive Vice President & Commercial Leader-EMEA by Bausch & Lomb Holdings, Inc., an Executive Vice President by Bausch + Lomb, Inc., a Chief Executive Officer by JADO Technologies GmbH, a Head-Sales & Marketing by Novartis AG, and a Marketing Manager by Eli Lilly & Co. He received his undergraduate degree from the University of Cape Town.

Charl van Zyl active positions

CompaniesPositionStart
RA PHARMACEUTICALS, INC. Director/Board Member 2020-04-01
H. LUNDBECK A/S Chief Executive Officer 2023-09-30
Director/Board Member 2017-05-09
Director/Board Member -

Former positions of Charl van Zyl

CompaniesPositionEnd
Corporate Officer/Principal 2016-12-31
Corporate Officer/Principal 2012-12-31
Chief Executive Officer 2008-12-31
NOVARTIS AG Sales & Marketing 2006-12-31
ELI LILLY AND COMPANY Sales & Marketing 2003-12-31
See the detail of Charl van Zyl's experience

Training of Charl van Zyl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Retail Trade

Health Technology

Health Technology